Skip to main content
$0.71 $0.01 (1.4%)

04:00 PM EST on 12/08/23

Vaxart, Inc (NASDAQ:VXRT)

CAPS Rating: 1 out of 5

Current Price $0.71 Mkt Cap $107.6M
Open $0.69 P/E Ratio -1.10
Prev. Close $0.71 Div. (Yield) $0.00 (0.0%)
Daily Range $0.68 - $0.71 Volume 449,344
52-Wk Range $0.56 - $1.59 Avg. Daily Vol. 649,600

Caps

How do you think NASDAQ:VXRT will perform against the market?

Add Stock to CAPS Watchlist

All Players

32 Outperform
21 Underperform
 

All-Star Players

1 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VXRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lemiwinx (20.54)
Submitted July 18, 2022

Gambling on their tablet based vaccine. Success means ability to capture the market that has an aversion to needles or are in a location where transportation and storage are difficult.

TMFjimhalley (< 20)
Submitted December 15, 2020

The company's valuation is too high considering that its oral COVID-19 vaccine candidate hasn't been approved. The clinical-stage biotech company is still looking for a blockbuster therapy and considering its lack of earnings, doesn't rate its… More

NASDAQ:VXRT Summary

Fools bullish on NASDAQ:VXRT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about VXRT.

Recs

1
Member Avatar lemiwinx (20.54) Submitted: 7/18/2022 6:56:38 PM : Outperform Start Price: $3.99 NASDAQ:VXRT Score: -101.84

Gambling on their tablet based vaccine. Success means ability to capture the market that has an aversion to needles or are in a location where transportation and storage are difficult.

Recs

2
Member Avatar PeteRock69 (< 20) Submitted: 4/25/2021 9:10:37 AM : Outperform Start Price: $5.68 NASDAQ:VXRT Score: -97.97

The Bears are hyper-focused on the lack of antibody response and totally dismissing the importance/value of increased T-cell response. Oral vaccines will be an absolute game changer.

Recs

3
Member Avatar TMFbonefish (41.80) Submitted: 12/16/2020 6:51:06 PM : Outperform Start Price: $7.60 NASDAQ:VXRT Score: -114.55

It's a gamble but the upside of a tablet based vaccine, especially for the seasonal flu, is immense. I think the upside outweighs the potential downside.

Leaderboard

Find the members with the highest scoring picks in VXRT.

Score Leader

whatsthepoint

whatsthepoint (99.88) Score: +303.19

The Score Leader is the player with the highest score across all their picks in VXRT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ChiefPaw 49.42 5/17/2018 1/22/2019 Underperform 1Y $5.09 -86.29% +69.23% +155.52 1 Comment
JoeySolitro1 99.97 3/9/2018 Underperform 5Y $5.80 -87.98% +66.24% +154.22 0 Comment
deepcrisis 98.74 3/9/2018 Underperform 5Y $5.98 -88.34% +65.63% +153.97 0 Comment
RTChokies 95.40 3/24/2020 Underperform 5Y $1.66 -57.99% +92.92% +150.92 0 Comment
Toprope101 98.57 3/17/2020 Underperform 5Y $1.76 -60.27% +84.83% +145.09 0 Comment
ClientNein 99.99 1/7/2019 Underperform 5Y $1.86 -62.51% +80.10% +142.61 0 Comment
SmartAce 99.83 3/17/2020 Underperform 5Y $1.70 -58.87% +81.60% +140.47 1 Comment
kdakota630 30.77 2/6/2019 Underperform 3M $2.19 -68.16% +68.61% +136.77 2 Comments
NorteClub 92.97 7/29/2020 Underperform 5Y $11.30 -93.83% +42.87% +136.70 0 Comment
RyanCoke 99.76 2/11/2019 Underperform NS $1.94 -64.06% +70.02% +134.07 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VXRT.